In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD)

Antiviral Research

Volumn 99, Issue 2, 2013, Pages 149-157

  Zhang, Xiao Min ^a   He, Dan Ni ^a   Zhou, Bin ^a   Pang, Ran ^a   Liu, Ke ^a   Zhao, Jin ^a   Chen, Pu Yan ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antiviral activity; Porcine Mx1 (poMx1); Protein transduction domain (PTD); Vesicular stomatitis virus (VSV)

Indexed keywords

HYBRID PROTEIN; MYXOVIRUS RESISTANCE PROTEIN; PROTEIN MX1; TAT PROTEIN TRANSDUCTION DOMAIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; ESCHERICHIA COLI; FEASIBILITY STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VERO CELL; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIVIRAL ACTIVITY; PORCINE MX1 (POMX1); PROTEIN TRANSDUCTION DOMAIN (PTD); VESICULAR STOMATITIS VIRUS (VSV);

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; MYXOVIRUS RESISTANCE PROTEINS; RECOMBINANT FUSION PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VERO CELLS; VESICULAR STOMATITIS INDIANA VIRUS; VIRUS REPLICATION;

EID: 84880611167     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.05.009     Document Type: Article

References (42)

1. Asano A., Ko J.H., Morozumi T., Hamashima N., Watanabe T. Polymorphisms and the antiviral property of porcine Mx1 protein. J. Vet. Med. Sci. 2002, 64:1085-1089.
2. Baise E., Pire G., Leroy M., Gérardin J., Goris N., De Clercq K., Kerkhofs P., Desmecht D. Conditional expression of type I interferon-induced bovine Mx1 GTPase in a stable transgenic vero cell line interferes with replication of vesicular stomatitis virus. J. Interferon Cytokine Res. 2004, 24(9):513-521.
3. Becker-Hapak M., McAllister S.S., Dowdy S.F. TAT-mediated protein transduction into mammalian cells. Methods 2001, 24(3):247-256.
4. Chaleston B., Stewart H.J. An interferon induced Mx protein: cDNA sequence and high-level expression in the endometrium of pregnantsheep. Gene 1993, 137:321-327.
5. Emeny J.M., Morgan M.J. Regulation of the interferon system: evidence that Vero cells have genetic defect in interferon production. J. Gen. Virol. 1979, 43:247-252.
6. Hailer O., Kochs G. Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffle 2002, 3:710-714.
7. Hakansson S., Jacobs A., Caffrey M. Heparin binding by the HIV-1 tat protein transduction domain. Protein. Sci 2001, 10:2138-2139.
8. Haller O., Stertz S., Kochs G. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect. 2007, 9:1636-1643.
9. Horisberger M.A. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 1992, 66:4705-4709.
10. Horisberger M.A., Gunst M.C. Interferon-induced proteins: identification of Mx proteins in various mammalian species. Virology 1991, 180:185-190.
11. Johnson K.M., Tesh R.B., Peralta P.H. Epidemiology of vesicular stomatitis virus: some new data and a hypothesis for transmission of the Indian serotype. J. Am. Vet. Med. Assoc. 1969, 155:2133-2140.
12. Letchworth G.J., Rodriguez L.L., Barrera J.D.C. Vesicular stomatitis. Vet. J. 1999, 157:239-260.
13. Li B., Fu D., Zhang Y., Xu Q., Ni L., Chang G., Zheng M., Gao B., Sun H., Chen G. Partial antiviral activities of the Asn631 chicken Mx against newcastle disease virus and vesicular stomatitis virus. Mol. Biol. Rep. 2012, 39:8415-8424.
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
15. Maniatis T., Fritsch E.F., Sambrook J. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, 888-897. second ed.
16. Morozumi T., Sumantri C., Nakajima E., Kobayashi E., Asano A., Oishi T., Mitsuhashi T., Watanabe T., Hamasima N. Three types of polymorphisms in exon 14 in porcine Mx1 gene. Biochem. Genet. 2001, 39:251-260.
17. Morozumi T., Naito T., Lan P.D., Nakajima E., Mitsuhashi T., Mikawa S., Hayashi T., Awata T., Uenishi H., Nagata K., Watanabe T., Hamasima N. Molecular cloning and characterization of porcine Mx2 gene. Mol. Immunol. 2009, 46:858-865.
18. Müller M., Winnacker E.L., Brem G. Molecular cloning of porcine Mx cDNAs: new members of a family of interferon-inducible proteins with homology to GTP-binding proteins. J. Interferon Res. 1992, 12:119-129.
19. Nakajima E., Morozumi T., Tsukamoto K., Watanabe T., Plastow G., Mitsuhashi T. A naturally occurring variant of porcine Mx1 associated with increased susceptibility to influenza virus in vitro. Biochem. Genet. 2007, 45:11-24.
20. Netherton C.L., Simpson J., Haller O., Wileman T.E., Takamatsu H.H., Monaghan P., Taylor G. Inhibition of a large double-stranded DNA virus by MxA protein. J. Virol. 2009, 83:2310-2320.
21. Palm M., Garigliany M.M., Cornet F., Desmecht D. Interferon-induced Sus scrofa Mx1 blocks endocytic traffic of incoming influenza A virus particles. Vet. Res. 2010, 41:29.
22. Pang R., He D.N., Zhou B., Liu K., Zhao J., Zhang X.M., Chen P.Y. In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation. Antiviral Res. 2013, 97:369-375.
23. Pavlovic J., Schröder A., Blank A., Pitossi F., Staeheli P. Mx proteins: GTPases involved in the interferon-induced antiviral state. Ciba Found. Symp. 1993, 176:233-243.
24. Plakhov I.V., Arlund E.E., Aoki C., Reiss C.S. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 1995, 209(1):257-262.
25. Qing G., Ma L.C., Khorchid A., Swapna G.V., Mal T.K., Takayama M.M., Xia B., Phadtare S., Ke H., Acton T., Montelione G.T., Ikura M., Inouye M. Cold-shock induced high-yield protein production in Escherichia coli. Nat. Biotechnol. 2004, 22:877-882.
26. Rainwater-Lovett K., Pauszek S.J., Kelley W.N., Rodriguez L.L. Molecular epidemiology of vesicular stomatitis New Jersey virus from the 2004-2005 US outbreak indicates a common origin with Mexican strains. J. Gen. Virol. 2007, 88:2042-2051.
27. Reed L.J., Muench H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
28. Rettenberger G., Bruch J., Fries R., Archibald A.L., Hameister H. Assignment of 19 porcine type I loci by somatic cell hybrid analysis detects new regions of conserved synteny between human and pig. Mamm. Genome 1996, 7:275-279.
29. Schnorr J.J., Schneider-Schaulies S., Simon-Jödicke A., Pavlovic J., Horisberger M.A., ter Meulen V. MxA-dependent inhibition of measles virus glyceprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 1993, 67:4760-4768.
30. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
31. Schwemmle M., Weining K.C., Richter M.F., Schumacher B., Staeheli P. Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology 1995, 206:545-554.
32. Staeheli P., Pavlovic J. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J. Virol. 1991, 65:4498-4601.
33. Tamura M., Ito K., Kunihiro S., Yamasaki C., Haragauchi M. Production of human b-actin and a mutant using a bacterial expression system with a cold shock vector. Protein Expr. Purif. 2011, 78:1-5.
34. Thomas A.V., Palm M., Broers A.D., Zezafoun H., Desmecht D.J. Genomic structure, promoter analysis, and expression of the porcine (Sus scrofa) Mx1 gene. Immunogenetics 2006, 58:383-389.
35. Vivès E., Brodin P., Lebleu B. A truncated HIV 1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1977, 272:16010-16017.
36. Vives E., Charneau P., van Rietschoten J., Rochat H., Bahraoui E. Effects of the tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized tat protein and tat peptides. J. Virol. 1994, 68:3343-3353.
37. Wang Y.F., Wang Z.H., Li Y., Zhang X.J., Sun Y., Li M., Qiu H.J. In vitro inhibition of the replication of classical swine fever virus by capsid-targeted virus inactivation. Antiviral. Res. 2010, 85:422-424.
38. Wheeler D.S., Dunsmore K.D., Wong H.R. Intracellular delivery of HSP70 using HIV-1 tat protein transduction domain. Biochem. Biophys. Res. Commun. 2003, 301:54-59.
39. Yang Y., Ma J., Song Z., Wu M. HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett. 2002, 532:36-44.
40. Yoo J.S., Kim C.M., Kim J.H., Kim J.Y., Oh J.W. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA. Antiviral Res. 2009, 82:122-133.
41. Zhang X., Shin J., Molitor T.W., Schook L.B., Rutherford M.S. Molecular responses of macrophages to porcine reproductive and respiratory syndrome virus infection. Virology 1999, 262:152-162.
42. Zurcher T., Pavlovic J., Staeheli P. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 1992, 187:796-800.